Glenmark gets USFDA nod to market generic version of Otezla tablets
The company has received final approval from the US Food & Drug Administration (USFDA) for Apremilast tablets in strength of 10 mg, 20 mg and 30 mg, the Mumbai-based drug maker said in a statement.
Glenmark said it has received approval from the US health regulator, image credit: Unsplash